臓器保存ソリューション市場- 世界の産業規模、シェア、動向、機会、予測、臓器タイプ別、用途別、地域別、競合別セグメント、2019-2029年

世界の臓器保存ソリューション市場は、2023年に2億5,735万米ドルと評価され、2029年までのCAGRは6.62%で、予測期間に目覚ましい成長を予測されています。

臓器保存ソリューションは、臓器の調達から移植までの全過程において、提供された臓器の生存可能性を維持する上で重要な役割を果たしています。臓器移植を必要とする人の増加に伴い、こうしたソリューションへの需要が高まっています。この需要は、この分野における絶え間ない技術的進歩と相まって、市場の成長を後押ししています。

また、臓器不全を引き起こすことが多い慢性疾患の有病率が上昇していることも、市場の拡大を後押ししています。例えば、腎臓や肝臓疾患の急増は移植件数の増加に直結しており、その結果、効果的な臓器保存ソリューションの需要が高まっています。

しかし、市場には課題もあります。大きな障害のひとつは、臓器移植手術や臓器保存ソリューション自体にかかる費用の高さです。さらに、臓器提供者の不足も市場成長の大きな障害となっています。こうした課題にもかかわらず、現在進行中の研究開発では、こうした障壁を克服し、移植に利用可能な臓器を確保するための革新的な解決策や戦略を見出すことに引き続き注力しています。

主な市場促進要因

臓器移植手術件数の増加

ヘルスケア支出の増加

主な市場課題

臓器保存ソリューションの高コスト

主要市場動向

生物学的および合成的ソリューションの需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界の臓器保存ソリューション市場に与える影響

第5章 世界の臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器別（心臓、肺、腎臓、肝臓、その他）
  • 用途別（静的冷蔵、低体温機械灌流、常温機械灌流、その他）
  • 地域別
  • 企業別（2023）
• 市場マップ

第6章 アジア太平洋地域の臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器の種類別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器の種類別
  • 用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器の種類別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器の種類別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの臓器保存ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 臓器の種類別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の臓器保存ソリューション市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• Waters Medical Systems LLC
• Xvivo Perfusion AB
• TransMedics Inc
• Organox Limited
• 21st Century Medicine
• Dr. Franz Koehler Chemie GmbH
• Accord Healthcare Limited
• Bridge to Life Ltd
• Perfusion Solutions, Inc.
• Lifeline Scientific Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

Global Organ Preservation Solution Market was valued at USD 257.35 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.62% through 2029. Organ preservation solutions play a crucial role in maintaining the viability of donated organs during the entire process, from procurement to transplantation. With the increasing number of individuals in need of organ transplants, there is a growing demand for these solutions. This demand, coupled with constant technological advancements in the field, has been instrumental in driving the market's growth.

Also, the market's expansion is propelled by the rising prevalence of chronic diseases that often result in organ failure. For instance, the surge in cases of kidney and liver diseases has directly contributed to an increase in the number of transplants, consequently boosting the demand for effective organ preservation solutions.

However, the market also faces certain challenges. One major obstacle is the high cost associated with organ transplantation procedures and the preservation solutions themselves. Additionally, the shortage of organ donors poses a significant hindrance to the market's growth. Despite these challenges, ongoing research and development efforts continue to focus on finding innovative solutions and strategies to overcome these barriers and ensure the availability of viable organs for transplantation.

Key Market Drivers

Growing Number of Organ Transplant Procedures

The number of organ transplant procedures has been steadily increasing each year, setting remarkable all-time records. In 2021 alone, a total of 41,354 organ transplants were performed in the United States, representing an impressive increase of 5.9 percent compared to the previous year. This positive trend continued to surge in 2022, with over 42,800 organ transplants successfully carried out, setting yet another annual record.

The significance of organ preservation solutions cannot be overstated, as they play a vital role in maintaining the viability of donated organs from the moment of procurement all the way through transplantation. As the demand for organ transplants continues to rise, driven by the growing number of individuals in need, the demand for these preservation solutions also rises in tandem. This increasing demand, coupled with remarkable technological advancements in the field, has been instrumental in propelling the overall growth of the market.

Moreover, the rising prevalence of chronic diseases leading to organ failure further underscores the crucial need for organ transplants. For example, there has been a surge in cases of kidney and liver diseases, resulting in a corresponding increase in the number of transplants performed. Consequently, this surge in transplants further intensifies the demand for effective organ preservation solutions, which are essential in ensuring the success and viability of these life-saving procedures.

Rise in Healthcare Expenditure

Healthcare expenditure worldwide has been on an upward trajectory for several years, driven by various factors. One significant factor is the aging population, as the number of elderly individuals requiring healthcare services continues to rise. Additionally, the increase in chronic diseases, such as cardiovascular conditions and diabetes, has contributed to the growing healthcare expenditure.

Also, advancements in medical technologies have played a crucial role in driving up healthcare costs. The development of innovative treatments and therapies, including precision medicine and gene therapies, has opened up new possibilities for patients but also comes with a higher price tag. Increased public health spending has contributed to the overall rise in healthcare expenditure. Governments around the world are recognizing the importance of investing in public health infrastructure and preventive measures to curb the spread of diseases and improve the overall well-being of their populations.

As healthcare expenditure continues to rise, the demand for organ transplants has also increased significantly. Organ preservation solutions play a vital role in maintaining the viability of donated organs throughout the entire transplantation process. With the prevalence of organ failures due to chronic diseases on the rise, the need for organ transplants has become more urgent than ever before.

The increase in healthcare expenditure has enabled more patients to afford life-saving organ transplant procedures, thereby further boosting the demand for organ preservation solutions. This, in turn, has led to increased investments in research and development (R&D) of advanced organ preservation technologies. For example, the development of normothermic perfusion techniques, which allow organs to be preserved at body temperature, has revolutionized the field of transplantation. These advancements in organ preservation technologies are made possible by the availability of increased funding for R&D, which further drives the growth of the organ preservation solution market.

The rise in healthcare expenditure worldwide is driven by various factors, including the aging population, the increase in chronic diseases, advancements in medical technologies, and increased public health spending. As healthcare expenditure continues to increase, the demand for organ transplants rises, leading to the growth of the organ preservation solution market. The availability of advanced organ preservation technologies, facilitated by increased investments in R&D, is transforming the field of transplantation and improving patient outcomes.

Key Market Challenges

High Cost of Organ Preservation Solutions

Organ preservation solutions play a critical role in ensuring the viability of donated organs throughout the entire process, from procurement to transplantation. As the demand for organ transplants continues to rise, the importance of these solutions becomes increasingly evident. However, the high costs associated with these solutions can pose significant challenges for many healthcare systems and patients, potentially impeding market growth.

The process of organ transplantation is a complex and costly endeavor that goes beyond the actual surgery itself. It encompasses various aspects, including organ procurement, preservation, and post-operative care. Among these, the organ preservation segment alone can account for a substantial portion of the overall costs involved.

For instance, in the United States, the average cost of preserving a kidney is estimated to be around USD 20,000. When it comes to more intricate organs like the heart and lungs, the costs can escalate even further. Such high expenses can exert considerable pressure on healthcare budgets and may prove to be prohibitive for patients residing in countries where healthcare costs are not fully covered by public health systems or insurance.

Given these challenges, finding innovative approaches to reduce the costs associated with organ preservation solutions is crucial. This would not only enhance accessibility to transplantation for patients in need but also alleviate the burden on healthcare systems worldwide.

Key Market Trends

Growing Demand of Biological and Synthetic Solutions

Biological and synthetic preservation solutions play a crucial role in maintaining the viability of donated organs from procurement to transplantation. The science of organ preservation is constantly being updated with new knowledge and ideas, leading to the development of more effective and efficient preservation solutions.

Biological solutions leverage the body's natural processes to preserve organs. One example is the use of blood or its components, such as red blood cells and plasma. These components not only provide essential nutrients and oxygen to the organ but also help to minimize damage during the preservation process by stabilizing the pH levels and preventing the formation of harmful free radicals. Additionally, biological solutions may include the use of cryoprotectants, which are substances that protect the cells and tissues from damage caused by freezing temperatures.

On the other hand, synthetic solutions are specifically designed to mimic the ideal conditions for organ preservation. These solutions often contain a balanced mix of electrolytes, nutrients, and other compounds that help to maintain organ function and structure. For example, synthetic preservation solutions may include antioxidants to protect against oxidative stress, as well as osmotic agents to maintain proper cellular hydration.

By continuously refining and optimizing both biological and synthetic preservation solutions, researchers and medical professionals aim to improve the success rates of organ transplantation and ultimately save more lives. Through ongoing research and innovation, the field of organ preservation continues to evolve, ensuring that donated organs remain viable and functional for transplantation, giving hope to patients in need of life-saving procedures.

Segmental Insights

Application Insights

The static cold storage segment is projected to experience rapid growth during the forecast period. Static cold storage has been a long-standing and reliable method of organ preservation in the medical community. This traditional approach involves carefully cooling the organ to slow down its metabolic processes. By reducing the rate of tissue decay, transplant teams are afforded valuable time to thoroughly prepare and execute the procedure.

In comparison to newer preservation techniques like normothermic perfusion, the static cold storage method remains a popular choice due to its simplicity and cost-effectiveness. Hospitals and clinics worldwide find it accessible, as it requires less specialized equipment and training. This accessibility ensures that organ preservation can be implemented effectively, benefiting patients in need of life-saving transplants.

Regional Insights

North America emerged as the dominant region in the Global Organ Preservation Solution Market in 2023, holding the largest market share in terms of value. In recent years, the region has witnessed a significant surge in cases of multi-organ failures, posing a challenge to the healthcare system. Additionally, there has been a noticeable shift in demographics, with a growing geriatric population that requires specialized care and attention. As a result, this has created an unprecedented demand for organ transplants and preservation techniques to meet the healthcare needs of the population.

When it comes to North America, particularly the United States, the healthcare infrastructure stands out as a shining example of excellence. With its well-established medical facilities, advanced technology, and highly skilled healthcare professionals, the region is equipped to handle the intricate complexities of organ transplantation and preservation. This robust healthcare system ensures that patients have access to the necessary resources and expertise, ensuring optimal outcomes for those in need of life-saving procedures.

Key Market Players

Waters Medical Systems LLC

Xvivo Perfusion AB

TransMedics Inc

Organox Limited

21st Century Medicine

Dr. Franz Koehler Chemie GmbH

Accord Healthcare Limited

Bridge to Life Ltd

Perfusion Solutions, Inc.

Lifeline Scientific Inc.

Report Scope:

In this report, the Global Organ Preservation Solution Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Solution Market, By Product:

Heart Lung Kidney Liver Others

Organ Preservation Solution Market, By Application:

Static Cold Storage Hypothermic Machine Perfusion Normothermic Machine Perfusion Others

Organ Preservation Solution Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Solution Market.

Available Customizations:

Global Organ Preservation Solution Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Organ Preservation Solution Market

5. Global Organ Preservation Solution Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Organ Type (Heart, Lung, Kidney, Liver, Others)
  • 5.2.2. By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2023)
• 5.3. Market Map

6. Asia Pacific Organ Preservation Solution Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Organ Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Organ Preservation Solution Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Organ Type
      • 6.3.1.2.2. By Application
  • 6.3.2. India Organ Preservation Solution Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Organ Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Australia Organ Preservation Solution Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Organ Type
      • 6.3.3.2.2. By Application
  • 6.3.4. Japan Organ Preservation Solution Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Organ Type
      • 6.3.4.2.2. By Application
  • 6.3.5. South Korea Organ Preservation Solution Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Organ Type
      • 6.3.5.2.2. By Application

7. Europe Organ Preservation Solution Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Organ Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Organ Preservation Solution Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Organ Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Organ Preservation Solution Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Organ Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Spain Organ Preservation Solution Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Organ Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Organ Preservation Solution Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Organ Type
      • 7.3.4.2.2. By Application
  • 7.3.5. United Kingdom Organ Preservation Solution Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Organ Type
      • 7.3.5.2.2. By Application

8. North America Organ Preservation Solution Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Organ Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Organ Preservation Solution Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Organ Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Mexico Organ Preservation Solution Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Organ Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Canada Organ Preservation Solution Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Organ Type
      • 8.3.3.2.2. By Application

9. South America Organ Preservation Solution Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Organ Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ Preservation Solution Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Organ Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Organ Preservation Solution Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Organ Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Organ Preservation Solution Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Organ Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Organ Preservation Solution Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Organ Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ Preservation Solution Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Organ Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Organ Preservation Solution Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Organ Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Organ Preservation Solution Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Organ Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Organ Preservation Solution Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Waters Medical Systems LLC
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
• 16.2. Xvivo Perfusion AB
• 16.3. TransMedics Inc
• 16.4. Organox Limited
• 16.5. 21st Century Medicine
• 16.6. Dr. Franz Koehler Chemie GmbH
• 16.7. Accord Healthcare Limited
• 16.8. Bridge to Life Ltd
• 16.9. Perfusion Solutions, Inc.
• 16.10. Lifeline Scientific Inc.

17. Strategic Recommendations

18. About Us & Disclaimer